CDC Director Rochelle Walensky has officially signed off on a recommendation by an independent panel of 11 experts to allow people with weakened immune function to get a third dose of certain COVID-19 vaccines.
Even then, however, the protection immunocompromised people get from vaccines is not as robust as someone who has healthy immune function, and some committee members were concerned that a third dose might come with a false sense of security.
“I think the reality is they’ll be safer, but still at incredibly high risk for severe disease and death,” she said. For now, people who’ve had the one-dose Johnson & Johnson vaccine have not been cleared to get a second dose of any vaccine. “We had to do what we’re doing based on the data we have in hand,” said Peter Marks, MD, director of the Center of Biologics Evaluation and Research at the FDA, the division of the agency that regulates vaccines.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
CDC vaccine advisers recommend additional Covid-19 vaccine dose for certain immunocompromised peopleVaccine advisers to the CDC voted on Friday to recommend an additional dose of Covid-19 vaccine for some immunocompromised people.
Weiterlesen »
Covid-19 Vaccine Booster for Immunocompromised People Backed by CDC PanelAn expert panel advising the U.S. Centers for Disease Control and Prevention voted to support administering additional messenger-RNA vaccine doses to certain people with weaker immune systems.
Weiterlesen »
CDC Strengthens Recommendation That Pregnant People Get COVID VaccineCDC Strengthens Recommendation That Pregnant People Get COVID Vaccine “The CDC is doubling down on their messaging which is this: the COVID-19 vaccine is safe and pregnant people should get the shot.”
Weiterlesen »
The FDA signed off on COVID-19 booster shots for immunocompromised peopleBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Weiterlesen »